4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001649094-25-000010
CHIEF OPERATING OFFICER sold 8,000 shares at an average $86.22 ($689,790)
- CHIEF OPERATING OFFICER acquired 8,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wassil Jim CHIEF OPERATING OFFICER | 2025-02-03 | Option exercise 10b5-1 | +8,000 | $2.42 | $19,360 | 213,695 | D: show line 1 in the form |
| Wassil Jim CHIEF OPERATING OFFICER | 2025-02-03 | Sale 10b5-1 | −5,314 | $86.00 | $456,983 | 208,381 | D: show line 2 in the form |
| Wassil Jim CHIEF OPERATING OFFICER | 2025-02-03 | Sale 10b5-1 | −2,666 | $86.67 | $231,049 | 205,715 | D: show line 3 in the form |
| Wassil Jim CHIEF OPERATING OFFICER | 2025-02-03 | Sale 10b5-1 | −20 | $87.94 | $1,759 | 205,695 | D: show line 4 in the form |
| Open-market sales · 8,000 sh · avg $86.22 · $689,790 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wassil Jim CHIEF OPERATING OFFICER | 2025-02-03 | Option exercise · Stock Option (right to buy) 10b5-1 | −8,000 | 2,638 | D: show line 5 in the form |
Loading xslF345X05/wk-form4_1738714793.xml…